Anchor Investment Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.08M | Sell |
6,272
-235
| -4% | -$128K | 0.26% | 102 |
|
|
2025
Q4 | $3.77M | Buy |
6,507
+649
| +11% | +$367K | 0.31% | 88 |
|
|
2025
Q3 | $2.84M | Sell |
5,858
-38
| -0.6% | -$17.7K | 0.24% | 111 |
|
|
2025
Q2 | $2.39M | Sell |
5,896
-5,726
| -49% | -$2.39M | 0.21% | 124 |
|
|
2025
Q1 | $5.78M | Buy |
11,622
+157
| +1% | +$85K | 0.54% | 50 |
|
|
2024
Q4 | $5.96M | Buy |
11,465
+99
| +0.9% | +$54.4K | 0.56% | 45 |
|
|
2024
Q3 | $7.03M | Buy |
11,366
+195
| +2% | +$115K | 0.66% | 38 |
|
|
2024
Q2 | $6.18M | Sell |
11,171
-131
| -1% | -$75K | 0.64% | 40 |
|
|
2024
Q1 | $6.57M | Buy |
11,302
+553
| +5% | +$310K | 0.69% | 36 |
|
|
2023
Q4 | $5.71M | Buy |
10,749
+1,738
| +19% | +$841K | 0.65% | 37 |
|
|
2023
Q3 | $4.56M | Buy |
9,011
+362
| +4% | +$193K | 0.6% | 41 |
|
|
2023
Q2 | $4.51M | Buy |
8,649
+300
| +4% | +$162K | 0.58% | 48 |
|
|
2023
Q1 | $4.81M | Sell |
8,349
-16
| -0.2% | -$9.02K | 0.66% | 39 |
|
|
2022
Q4 | $4.61M | Buy |
8,365
+447
| +6% | +$237K | 0.66% | 39 |
|
|
2022
Q3 | $4.02M | Sell |
7,918
-197
| -2% | -$110K | 0.62% | 42 |
|
|
2022
Q2 | $4.41M | Sell |
8,115
-485
| -6% | -$267K | 0.64% | 43 |
|
|
2022
Q1 | $5.08M | Buy |
8,600
+87
| +1% | +$50K | 0.64% | 42 |
|
|
2021
Q4 | $5.68M | Buy |
8,513
+84
| +1% | +$52.4K | 0.71% | 35 |
|
|
2021
Q3 | $4.82M | Sell |
8,429
-14
| -0.2% | -$7.68K | 0.67% | 40 |
|
|
2021
Q2 | $4.26M | Buy |
8,443
+214
| +3% | +$101K | 0.59% | 45 |
|
|
2021
Q1 | $3.76M | Buy |
8,229
+1,022
| +14% | +$488K | 0.57% | 51 |
|
|
2020
Q4 | $3.36M | Sell |
7,207
-5
| -0.1% | -$2.34K | 0.6% | 49 |
|
|
2020
Q3 | $3.18M | Buy |
7,212
+475
| +7% | +$196K | 0.65% | 45 |
|
|
2020
Q2 | $2.44M | Sell |
6,737
-55
| -0.8% | -$18.4K | 0.55% | 55 |
|
|
2020
Q1 | $1.93M | Sell |
6,792
-210
| -3% | -$66.2K | 0.5% | 62 |
|
|
2019
Q4 | $2.27M | Buy |
7,002
+10
| +0.1% | +$3.03K | 0.49% | 61 |
|
|
2019
Q3 | $2.04M | Sell |
6,992
-192
| -3% | -$55K | 0.47% | 69 |
|
|
2019
Q2 | $2.11M | Buy |
7,184
+15
| +0.2% | +$4.13K | 0.5% | 60 |
|
|
2019
Q1 | $1.96M | Sell |
7,169
-492
| -6% | -$122K | 0.49% | 57 |
|
|
2018
Q4 | $1.71M | Sell |
7,661
-215
| -3% | -$50.4K | 0.49% | 58 |
|
|
2018
Q3 | $1.92M | Sell |
7,876
-729
| -8% | -$168K | 0.44% | 61 |
|
|
2018
Q2 | $1.78M | Buy |
8,605
+73
| +0.9% | +$15.5K | 0.44% | 63 |
|
|
2018
Q1 | $1.76M | Buy |
8,532
+125
| +1% | +$26.2K | 0.46% | 61 |
|
|
2017
Q4 | $1.6M | Sell |
8,407
-93
| -1% | -$17.8K | 0.42% | 68 |
|
|
2017
Q3 | $1.61M | Buy |
8,500
+180
| +2% | +$32.6K | 0.47% | 63 |
|
|
2017
Q2 | $1.45M | Sell |
8,320
-155
| -2% | -$26K | 0.48% | 60 |
|
|
2017
Q1 | $1.3M | Buy |
8,475
+55
| +0.7% | +$8.41K | 0.45% | 69 |
|
|
2016
Q4 | $1.19M | Buy |
8,420
+235
| +3% | +$34.6K | 0.44% | 66 |
|
|
2016
Q3 | $1.3M | Buy |
8,185
+855
| +12% | +$132K | 0.5% | 58 |
|
|
2016
Q2 | $1.08M | Buy |
7,330
+150
| +2% | +$22.1K | 0.43% | 71 |
|
|
2016
Q1 | $1.02M | Buy |
+7,180
| New | +$962K | 0.42% | 72 |
|
Other funds holding TMO
VCM
Anchor Investment Management's TMO Position: Q1 2026 in Review
Anchor Investment Management reduced its Thermo Fisher Scientific (TMO) stake by 3.6% in Q1 2026, selling an estimated $128K and leaving 6,272 shares worth $3.08M. The position accounts for 0.26% of the portfolio, ranked #102.
Anchor Investment Management first reported a position in TMO in Q1 2016 and has held it in 41 quarters since. The position peaked at $7.03M in Q3 2024. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Anchor Investment Management held 6,272 shares of Thermo Fisher Scientific worth $3.08M as of Q1 2026.
- Anchor Investment Management sold 235 Thermo Fisher Scientific shares in Q1 2026, an estimated $128K.
- Thermo Fisher Scientific made up 0.26% of Anchor Investment Management's portfolio in Q1 2026, its #102 holding.
- Anchor Investment Management first reported a position in Thermo Fisher Scientific in Q1 2016 and has held it in 41 quarters since.
- Anchor Investment Management's Thermo Fisher Scientific position peaked at $7.03M in Q3 2024.
- 2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Anchor Investment Management's 13F filing for Q1 2026, filed 1 May 2026.